FDA approved dissolution test specifications differ from USP. Diclofenac Tablets - Clinical Pharmacology Mechanism of Action Diclofenac sodium extended-release tablets have analgesic, anti-inflammatory, and antipyretic properties. The mechanism of action of diclofenac sodium extended-release tablets, like that...
戊戌数据药品标准数据库提供了Diclofenac Sodium Delayed-Release Tablets美国药典标准的查询检索,包括Diclofenac Sodium Delayed-Release Tablets美国药典的版本USP42-NF37页码,以及药典的查询与下载.
Diclofenac sodium delayed-release tablets is a benzene-acetic acid derivative. Diclofenac sodium is a white or slightly yellowish crystalline powder and is sparingly soluble in water at 25°C. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid, monosodium salt. The molecular wei...
Carefully consider the potential benefits and risks of Voltaren®-XR (diclofenac sodium extended-release) tablets, USP and other treatment options before deciding to use Voltaren-XR. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (seeWARNINGS...
The mechanism of action of diclofenac sodium delayed-release tablets, like that of other NSAIDs, is not completely understood but involves inhibition of cyclooxygenase (COX-1 and COX-2). Diclofenac is a potent inhibitor of prostaglandin synthesisin vitro. Diclofenac concentrations reached during therap...
英文名称:Diclofenac sodium CAS编号:15307-79-6 保质期:详见说明书个月 保存条件:低温冷藏 注意事项:Diclofenac sodium供应商纯度高,检测/鉴别精确,稳定性强,为了防止产品含量降低,不宜暴露在空气中,应防潮、避光和抗氧化包装,保存应以提高物质稳定性为原则,尽可能在干燥、低温条件下储藏(液体或易潮解物质分装在熔...
Diclofenac Sodium Delayed-Release Tablets 查看 美国药典 USPNF 2023 Issue 1 查看 Diclofenac Sodium Extended-Release Tablets 查看 美国药典 USPNF 2023 Issue 1 查看 Diclofenac Sodium Topical Solution 查看 美国药典 USPNF 2023 Issue 1 查看 Diclofenac sodium 查看 欧洲药典 EP11.2 2521 查看 Diclofenac Sodium...
英文名称:Diclofenac sodium15307-79-6 CAS No.:15307-79-6 中文名:双氯芬酸钠 别名: 分子式:C14H10Cl2NNaO2 性状:Powder 纯度:98.0% 化学药品标准物质的分类: Diclofenac sodium15307-79-61.按来源: (1)国际化学标准物质(WHO) (2)美国药典标准物质(USPC,USP) ...
别名 Diclofenac potassium (USP)、CGP 45840B、CGP-45840B + [7] 靶点 COX 作用机制 COX抑制剂(环氧化酶抑制剂) 治疗领域 神经系统疾病 在研适应症 偏头痛急性疼痛疼痛 非在研适应症 骨关节炎术后疼痛原发性痛经+ [1] 原研机构 Novartis Pharmaceuticals Corp. ...
[求助]求双氯芬酸钠缓释片 Diclofenac sodium sustained-release tablets 的USP37-39标准！求双氯芬酸...